The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...

Q2 2025 Earnings Call Transcript January 30, 2025 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $1.93, ...

GI Alliance, along with our recently completed Integrated Oncology Network transaction ... Second quarter revenue for Cardinal Health's global medical products and distribution segment increased ...

Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...

Cardinal Health Inc (CAH) raises EPS guidance despite a 4% revenue decline, driven by robust pharmaceutical segment performance and strategic acquisitions.

Segment Profit: segment revenue minus (segment cost of products sold and segment distribution ... Non-GAAP net earnings attributable to Cardinal Health, Inc.: net earnings attributable to ...

Ansell’s focus is on its key brands across industrial and healthcare settings. Each market is quite fragmented and Ansell’s market share varies by subsegment, but the firm has consistently held the ...

"We delivered strong second quarter financial results while taking significant strategic and operational actions to position us for future growth," said Jason Hollar, CEO of Cardinal Health.

With a positive outlook, McKesson raised its fiscal 2025 adjusted EPS guidance to a range of $32.55 to $32.95, indicating ...